FRES

Fresh2

1.01 USD
-0.01
0.98%
At close Nov 15, 4:00 PM EST
After hours
1.00
-0.01
0.99%
1 day
-0.98%
5 days
-16.53%
1 month
-34.42%
3 months
-45.99%
6 months
-75.12%
Year to date
-85.85%
1 year
-91.65%
5 years
-99.96%
10 years
-99.96%
 

About: Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Employees: 75

0
Funds holding %
of 6,704 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 3 [Q2] → 3 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.01% less ownership

Funds ownership: 0.01% [Q2] → 0% (-0.01%) [Q3]

93% less capital invested

Capital invested by funds: $21.7K [Q2] → $1.48K (-$20.2K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Research analyst outlook

We haven’t received any recent analyst ratings for FRES.

Financial journalist opinion

Charts implemented using Lightweight Charts™